Sichuan Kelun Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002422.SZ

Sichuan Kelun Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2023: USD 345.94 M

Sichuan Kelun Pharmaceutical Co., Ltd. Net Income is USD 345.94 M for the year ending December 31, 2023, a 39.99% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Sichuan Kelun Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2022 was USD 247.12 M, a 80.87% change year over year.
Sichuan Kelun Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2021 was USD 136.62 M, a 7.53% change year over year.
Sichuan Kelun Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2020 was USD 127.06 M, a -5.65% change year over year.
Sichuan Kelun Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2019 was USD 134.68 M, a -23.64% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

Shenzhen Stock Exchange: 002422.SZ

Sichuan Kelun Pharmaceutical Co., Ltd.

CEO	Mr. Sichuan Liu
IPO Date	June 3, 2010
Location	China
Headquarters	No.36 West Baihua Road
Employees	19,798
Sector	Health Care
Industries Pharmaceuticals

Description

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers IV solutions; injectable powder and small volume parenteral; oral preparation; intermediates and APIs; and peritoneal dialysis solutions. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.

Key trends

Past 5 years